Background: Current phenotyping of chronic rhinosinusitis (CRS) into CRS with nasal polyps and without nasal polyps may not adequately reflect the pathophysiologic diversity within CRS.
Introduction
Chronic rhinosinusitis (CRS) is a disabling disease affecting 10.9% of the European 1 and 13.4% of the American 2 general population. CRS is defined by symptoms and clinical signs, and diagnosis may be supported by nasal endoscopy and CT scanning 3 . In a European multicenter epidemiological study involving 56,000 individuals, it recently has been demonstrated that cigarette smoking increases the risk of CRS 1 ; of interest, CRS is also associated with late-onset asthma 4 . However, questionnaire-based population studies are limited in further defining possible subgroups relevant for these associations 5 . Indeed, CRS
shows remarkable heterogeneity, both at the clinical phenotype level and at the molecular pathophysiological level. Current consensus in Europe and the US discerns two major phenotypes -defined as subgroups of patients with homogeneous clinically observable characteristics 6 -based on nasal endoscopic findings: chronic rhinosinusitis with nasal polyps (CRSwNP) and chronic rhinosinusitis without nasal polyps (CRSsNP). Furthermore, there are additional subtypes such as allergic fungal rhinosinusitis, CRS associated with aspirinexacerbated respiratory disease, and with cystic fibrosis which may present as CRSwNP or CRSwNP in Caucasians 7, 8 . However, subsequent studies reported a wider spectrum of immunologic profiles, especially in non-Caucasian phenotypes 9 , expressing a neutrophilic type of inflammation with involvement of other T-cell subsets such as Th1 and Th17 cells.
Furthermore, the simultaneous expression of different Th cell types within a single tissue was demonstrated 10 .
Thus, the simple differentiation in Th1 and Th2 disease does not encompass the molecular diversity in CRS, and the clinical phenotype does not adequately identify the immunological profile. Therefore we sought to identify inflammatory endotypes of CRS -defined as "subtypes of disease with a unique pathomechanism, functionally and pathologically different from others by the involvement of a specific molecule or cell". 11 For this, we aimed to cluster CRS subjects solely based on immune markers in a clinical phenotype-free approach.
Secondarily, we aimed to match these endotypes with clinical phenotypes and with selected clinical parameters, of which we already have identified association with immune markers 12, 13 . This approach would also facilitate the identification of therapeutic targets and predict response to those approaches, e.g. biologicals.
Methods

Study design
The study was designed as a multicenter case-control study carried out by the Ga²len Sinusitis
Cohort group (principal investigator C. Bachert) in the framework of the European FP6 research initiative. The ENT departments in tertiary referral academic hospitals of Ghent, Leuven, Amsterdam, Barcelona, London, Berlin, Helsinki, Lodz, Malmö, and Stockholm participated in this study. This study was approved by the ethical committees of all individual institutions involved in data and tissue collection. Informed consent was obtained from all subjects before sample collection.
Patient population
Patients with CRS (defined by EPOS-criteria based on symptoms, nasal endoscopy and computed tomography of the sinuses 3 ) were included as cases, and subjects undergoing inferior turbinate surgery with no signs of CRS were included as controls. Excluded were subjects with an acute exacerbation of rhinosinusitis 2 weeks preceding inclusion, subjects with immunodeficiencies, cystic fibrosis patients, and subjects who used oral or nasal steroids in the 4 weeks preceding surgery, or anti-leukotrienes in 2 weeks preceding inclusion. In total, 917 subjects were recruited, of whom 682 cases (of which 65% CRSwNP) and 187 controls.
Subjects underwent a standardized skin prick test 14 and subjects were registered as asthmatic based on a clinical diagnosis. Patients were considered allergic on clinical grounds (positive skin prick test or provocation tests or specific IgE to inhalant allergens plus allergy symptoms present).
At a maximum of 12 months after inclusion, a portion of the subjects underwent functional endoscopic sinus surgery, and controls underwent partial inferior turbinotomy during septal surgery (226 CRS patients and 106 controls). Controls having allergic rhinitis were not excluded. The indications for surgery and its procedures were based on clinical decisions independent from the participation in the study. Tissue was collected from nasal polyps or sinus mucosa in patients with CRS, and from the inferior turbinates in control subjects. Tissue was separated from bone fragments, snap-frozen in liquid nitrogen and stored at -80°C.
Control tissues were not used in the cluster analyses of the CRS patients, but solely served to determine increased concentrations of markers above normal.
Measurement of inflammatory markers
For tissue analysis, we selected 14 markers (Table 1) To analyze relationships between variables, we performed principal component analysis, after which orthogonal rotation with Kaiser normalization was performed, and only variables with loadings higher than 0.4 were retained. Next, we performed cluster analysis on the variables using ascendant hierarchical clustering based on the correlation ratio and the mixed principal component analysis ( 17 , and the optimal number of cluster was determined using the Rand statistic.
For cluster analysis of individual cases, a dissimilarity matrix according to Gower was calculated, which allows both ordinal and binomial data. Next, clusters were calculated using the partitioning around medoids method, of which outcomes with the number of clusters ranging from 2 to 15 clusters were generated. The optimal number of clusters was based on the elbow (maximum change) of the scree plot of the mean silhouette width, Baker-Hubert Gamma statistic 18 , and Hubert-Levin C index 19 . Additionally, the optimal number of clusters was assessed using Jaccard stability after bootstrap resampling 20 and visual inspection of the clusplot after multidimensional scaling 20 .
For descriptive characterization of individual clusters, cytokine and phenotype data from each cluster were tested for difference from the control group (Mann Whitney U and logistic regression). Next, between-cluster differences of all parameters, as well as phenotype parameters, were tested using Kruskal-Wallis with multiple group comparison with
Benjamini-Hochberg adjustment for multiple testing, or Tukey contrasts in logistic models for binomial parameters. For visualization of clusters, a "clusplot" was drawn, plotting individuals in two dimensions after multidimensional scaling.
As an aid in interpretation of inflammatory patterns, each cytokine in each cluster was categorized as increased compared to controls only, and increased compared to controls and to 2, 3 or 6 other clusters, or no difference from control or other clusters. Furthermore, for each cluster we interpreted the inflammatory patterns based on a high proportion of positive categorical variables or on increased concentrations of continuous variables, compared to controls and other clusters. The pattern for interpretation is listed in Table 1 . A modified heatmap was created (Figure 3 ), after ordering and grouping clusters with similar characteristics, and ordering variables according to the previous principal component analysis.
The variables that were used categorically in the cluster analysis, were additionally tabulated with their continuous values.
Results
Of the 226 cases and 106 controls who underwent surgery, 173 cases and 89 controls had adequate amount of tissue prelevated to carry out all intended analyses. Demographic, phenotypic and cytokine data of cases and controls are tabulated in Table 2 ; demographic data of the sample included were not different from the total cohort. Cases had a significantly higher age, and had a higher prevalence of smoking history and asthma. Cases had significantly higher concentrations than controls of IL-6, IL-8, albumin, MPO, ECP, IgE, and had significantly higher proportion of concentration above detection limit for IL-5, IFN-γ and SE-IgE (see Table 2 ). Table E1 and Figure 1A Clustering of all CRS individuals using cytokine measurements, irrespective of phenotype information, resulted in an optimal outcome of 10 clusters (details are given in Figure E1 and Table E2 ). The clusters were well separated from each other, as illustrated in the cluster plot ( Figure 2 ). Tests for between-cluster differences and differences from controls showed that for all cytokines, except TGF-β1 and IL-1β, there was at least one cluster having significantly higher concentrations than any other cluster. Compared to the control group, all cytokines except TGF-β1 were significantly increased (p<0,05) in at least one cluster. Not all clusters that had a significant difference from the control group, had differences with other clusters.
Principal component analysis (illustrated in
IL-22 concentrations did not differ significantly from controls, however there were multiple significant between-group differences.
Analogously, clinical parameters (which were not used in the cluster analysis) were analyzed within clusters and compared with controls ( Figure 3 ). The proportion of CRSwNP was significantly different between clusters, with clusters 1-3 significantly lower than most clusters and clusters 8-10 significantly higher than most clusters. Asthma prevalence was significantly different from controls , and differed significantly between clusters. Age, gender, prevalence of allergy and of reported aspirin sensitivity were not significantly different between clusters (Table E3) .
To characterize the clusters, means and ratios of cytokine and phenotype data were calculated and tabulated as a heatmap ( Figure 3 ). The most striking differentiation was formed by the IL- 
Discussion
We here present inflammatory endotypes of chronic rhinosinusitis, based on a cluster analysis solely based on biomarkers, and secondarily we correlate these to clinical characteristics (phenotypes). In this cohort of European subjects who underwent surgery for CRS, we observed considerable variability in the data, so that multiple homogeneous subgroups (clusters) could be differentiated. This observation indicates that CRS is not a homogeneous inflammatory disease, and endotypes are present with a wide diversity of inflammatory profiles. To our knowledge, this is the first study to report the existence of inflammatory endotypes within CRS, unbiased by phenotype data. Furthermore, we demonstrated that the newly defined endotypes mirror clinical phenotypes, supporting their clinical relevance.
To determine which parameters were relevant in the generation of this diversity, principal component analysis and clustering of variables showed that diversity in our samples was driven by five groups of related cytokines: (1) markers of eosinophilic, Th2-driven inflammation and antibody production (ECP, IL-5, IgE and SE-IgE) together with albumin (2) neutrophilic and pro-inflammatory cytokines (IL1β, IL6, IL8, MPO) (3) Th17 or Th22 related markers (IL-17A, IL-22, TNF-α, and (4) the Th1 marker IFN-γ. Moreover, TGF-β1 had a separate but small contribution to variability in our subjects.
These observations have previously been observed, albeit in specific CRS subgroups. The correlations of ECP, IL5 and IgE confirm previous data in Caucasian nasal polyps, where inflammation is dominated by activated eosinophils 15 and IgE concentrations were related to eosinophilic inflammation 21 . The association of albumin with eosinophil products can be related to observations in nasal polyps where increased albumin deposition has been thought to be caused by eosinophil-driven inflammation 15 . The expression of neutrophilic and proinflammatory cytokines has been observed previously in Chinese nasal polyp patients 9 and more specifically in Chinese nasal polyp patients that were IL-5/IL-17/IFN-γ negative 22 .
Importantly, our observations were present in the whole CRS group, whereas previous results were limited to specific subgroups, implicating that that these previously described mechanisms can be extrapolated to the overall CRS group, and might not be restricted to the CRSwNP phenotype. Indeed, separate post hoc analyses in the CRSsNP and CRSwNP subgroup yielded similar principal components (data not shown), indicating that even in the lower concentration ranges, concentration gradients of cytokines are present and meaningful.
These findings indicate that CRS is not a dichotomal or a one-dimensional linear spectrum of diseases but rather multidimensional with different polarizations on the main inflammatory axes.
When individuals were clustered into inflammatory endotypes, our analysis resulted in 10 clusters of which each cytokine pattern was interpreted, and accordingly, clusters could be grouped together (summarized in Figure 4 ). To characterize each cluster's phenotype, we correlated clusters with selected phenotype parameters such as nasal polyp prevalence and asthma comorbidity. Importantly, this was a post-hoc analysis, and the phenotype information was not used during cluster analysis.
We show a strong correlation with the phenotype, with three clusters almost exclusively composed of CRSsNP without asthma comorbidity, and three clusters almost exclusively of CRSwNP with strongly increased asthma prevalence. Presence of IL-5 remains the paramount factor dictating the phenotype with nasal polyps and asthma, in line with previous evidence 13 .
SE-IgE presence remains associated with nasal polyps with intense eosinophilic inflammation with very high IgE concentrations, and asthma comorbidity, as demonstrated before 13 . As summarized in Figure 4 , clusters can accordingly be grouped in four IL-5 negative clusters, three moderately increased IL-5 positive clusters, and three IL-5 high clusters of which two SE-IgE positive clusters.
However, in clusters 4 to 7 there is a mixture of phenotypes, with polyp prevalence around 50 to 60% and albumin moderately increased, although each of these clusters had a distinct inflammatory profile. Three of these clusters had moderate increase in IL-5 concentrations and further had an eosinophilic pattern, but differed in terms of IFN-γ and TNF-α expression.
This might indicate that for some groups, IL-5 is not the only key to edema and polyp formation, and other, possibly unmeasured factors might play a role in differentiation towards a polyp. Our study was limited to the major cytokines, and the amount of tissue available limited further analyses. Also, subjects were allocated to a phenotype during office endoscopy before surgery, and the clinical differentiation might be unclear in some cases were polyps were only observed during surgery. In cases of middle turbinate-confined polypoid oedema, the phenotype might not be clear-cut during office endoscopy, and it has been shown that early stage nasal polyps already show eosinophilic inflammation 15, 23 . The production of Th17-family derived cytokines IL-17A and IL-22 correlated modestly as was shown by the principal components analysis. Reasons for this modest correlation are apparent when analyzing the cluster profiles; in cluster 4 and 8 the IL-17A production was paired with increased IL-22 production whereas in clusters 2 and 7, only increased IL-22 production was present, possibly indicating Th22 involvement in these clusters. Interestingly, in cluster 10, which was a SE-IgE positive cluster, the increased IL-22 production was paired with only marginal IL-17A production, indicating a Th22 involvement which also was observed to be induced by staphylococcal enterotoxins in atopic dermatitis 26 . Additionally, we observed increased TNF-α levels in all of these clusters, consistent with the observation that both Th17 and Th22 cells may induce TNF-α production 27 . However, IL-22 concentrations did not differ from controls, and this effect remained after excluding allergic controls (data not shown). The reasons for this discrepancy with coherent between-cluster differences are not clear and the relevance of Th22 in the pathology of CRS should be further elucidated.
Surprisingly, we found little contribution of TGF-β1 to the variability of our data; the TGF-β1 concentration had no significant between-cluster differences and did not differ between clusters and the control group. Previously, expression of TGF-β signaling was in Caucasians found to be increased in CRSsNP, sharply contrasting to a decreased signaling in CRSwNP 28 .
These findings were later confirmed in Chinese CRS subjects 29 , although these are characterized by different T effector cell profiles than their Caucasian counterparts 9 . In our study, CRSsNP subjects were confirmed to have increased TGF-β1 concentrations compared to CRSwNP subjects and controls (p<0.001, data not shown 31 . However, these approaches are inherently different from our study, as we based our cluster analysis solely on inflammatory mediators to obtain endotypes, and only in a posthoc analysis we compared these with selected phenotype parameters such as nasal polyp prevalence and asthma comorbidity.
Our study has some limitations. Our definition of endotypes was entirely based on inflammatory biomarkers. However, for asthma, it is proposed that more parameters, such as clinical characteristics, genetics and treatment responses should be included for the definition of an endotype 33 . We aimed to propose 'inflammatory endotypes', and further studies are needed incorporating clinical characteristics, genetics, remodeling parameters, and treatment responses to further define these endotypes. Some of these endotypes might eventually be merged or split with other endotypes given these additional studies.
The use of cluster analysis is potentially a limiting factor in this study. As cluster analysis is no inferential statistical technique, there is no probability outcome. The technique generates multiple possible solutions in terms of number of clusters, of which the most relevant solution is selected by the examiner. To scrutinize this process, the selection of the best number of clusters was based on objective criteria such as the Hubert-Levine index as a measure of internal cluster validity, as well as bootstrap resampling of the cluster analysis. Even though all these measure resulted in a certain optimal number of clusters, it is not our aim to claim a final definite classification in which all CRS subjects should be categorized, but instead, illustrate the diversity in inflammatory profiles.
The inflammatory profile of asthmatics has been found to evolve over time within subjects.
As we only analyzed our subjects on one time point, possible variability of the inflammatory endotype over time limits our findings. Indeed, when comparing the profile of nasal polyp patients undergoing two surgeries due to disease recurrence, it has been found that all nasal polyps remained IL-5 positive over a period of in average 5 years, however in some patients IL-17 became co-expressed 12 . To determine the clinical and therapeutic utility of the inflammatory endotypes, further longitudinal studies are needed, evaluating their stability over time, in relation to possible treatment and environmental changes.
The applicability of our study, which was done in a European population, to other regions in the world, remains at question as well. For example, the high smoking prevalence in our study was comparable to the European average, but lower smoking prevalences in North America might affect the inflammatory endotype. Other lifestyle and environmental factors might affect the endotype, and global studies are needed to address these.
Furthermore, Our choice of biomarkers did not cover remodeling parameters, and we have not included cellular contents. However, the current analysis enables the appreciation of the possible target groups for various therapeutic monoclonal antibodies currently in study.
In summary, we have identified distinct inflammatory endotypes within chronic rhinosinusitis, which largely correlated with phenotypes and further differentiated them.
Endotypes clearly provide a more accurate description of the inflammatory mechanisms involved than phenotype information only, and inflammation in CRS may be more diverse than previously assumed. CRS inflammation should be considered as multidimensionally heterogeneous on the Th1, Th2, Th17, eosinophilic/neutrophilic, pro-inflammatory, superantigen and possibly Th22 axes. Inflammatory endotypes might be of importance for the prognosis of comorbid asthma development or disease recurrence after surgery 12 . As recent monoclonal antibody approaches such as omalizumab 34 , mepolizumab 35 or dupilumab target specific cytokines or pathways, it is expected that an approach based on biomarker-defined clusters would identify responders to these drugs. Nasal levels of IL-5 for example were found to predict responders to reslizumab, an anti-IL5 monoclonal antibody 36 . The clinical applicability of inflammatory endotypes, however, would be aided by the availability of noninvasive serum or nasal secretion markers; a range of markers is currently under investigation in the same cohort of CRS patients. Rows define clusters of CRS cases; these were arbitrarily (non-hierarchically) ordered according to the cytokine pattern. Columns indicate the variables used for cluster analysis, which were ordered according to their interrelationship in component analysis. Geometric mean concentrations are given for each cluster. Some variables were used in the cluster analysis in a categorical manner because of a high rate of below detection limit measurements (IFN-γ, IL-5, SE-IgE, TNF-α and IL-17). For these, proportion of positive values are given, and additionally geometric means are given for illustrative purposes. Selected phenotypic information (proportion with nasal polyps, with asthma, allergy) is tabulated, although not used in cluster analysis. For characterization of the clusters, multiple group comparison for between-cluster differences, and for differences with the control group, is visualized with a color code as in legend. For CRSwNP proportion, only between-cluster differences were calculated. *In clusters 2,4,7,8, IL-22 concentrations were significantly higher than in clusters 1,5,6 and 9, but were not different from controls. We generated different clusterings with a number of clusters (k) ranging from 2 to 15. To validate clustering outcomes, we used internal cluster quality measures, as indicated in graphs A to F. For each of the possible number of clusters, an index is calculated reflecting the between-subject similarity within clusters, and the dissimilarity between clusters. This index usually increases monotonically with increasing number of clusters, and the optimal is determined to be at the elbow of its plot, where the change in index (difference with k-1 and k+1) is at a maximum. There are several possible indices available. We used mean silhouette width, Baker-Hubert Gamma statistic, and Hubert-Levin C index as they are relying on dissimilarity data (allowing mixed continuous and categorical data, as is the case in our sample). We mostly relied on the C index as this is especially fit for mixed type data. The following plots show the index for k = 2-15 possible clusters, and the change (delta) in index compared to k-1. Note that for the C index lower values are better. The results from the internal cluster quality indexes produce a good signal at either 4-5 clusters and 8-10 clusters. Secondly we assessed clustering stability after resampling of the cluster analysis. Here, data is resampled (for 1,000 iterations) using several schemes (bootstrap, subsetting of the data) and clusters are recalculated. The Jaccard similarities of the original clusters to the most similar clusters in the resampled data are computed, giving an estimate of the stability of a cluster. In the range of k = 2-15, average stability peaked at 5 and 10 clusters. Lastly we assessed cluster validity using visual inspection of the clusterplot. The subjects are plotted in a two-dimensional space after multidimensional scaling, which is a technique maximizing the dissimilarities between subjects projected in two dimensions. Plots were created for the 5 and 10-cluster solution, and are illustrated in pane G and H. The five cluster solution clearly showed unresolved clusters, which were correctly discovered in the 10-cluster solution. 
Legend:
Concentration significantly higher than controls and higher than 6 or more other clusters Concentration significantly higher than controls and higher than 3 or more other clusters Concentration significantly higher than controls and higher than 2 or more other clusters Concentration significantly higher than controls but not higher than other clusters 
